Upgrade to SI Premium - Free Trial

Amarin Corp. (AMRN)

15.35 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26 *Est.)

Latest Headlines

U.S. Supreme Court rules in favor of generic drugmaker Hikma in 'skinny label' patent dispute over Amarin heart drug vascepa June 4, 2026 10:02 AM - StreetInsider Amarin presents analysis on risk-weighted apoB for cardiovascular patients May 27, 2026 8:01 AM - StreetInsider New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated May 27, 2026 8:00 AM - Globe NewsWire Amarin Corp. (AMRN) Misses Q1 EPS by 3c April 29, 2026 7:45 AM - StreetInsider Amarin Reports 2026 First Quarter Financial Results April 29, 2026 7:00 AM - StreetInsider Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: Bonfiglio Patrice Eadon April 22, 2026 5:00 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: Cohen Paul April 21, 2026 5:00 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: Odysseas Kostas D April 21, 2026 5:00 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: Sullivan Diane E. April 21, 2026 5:00 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: O'Connor Oliver April 21, 2026 5:00 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: Horn Keith April 21, 2026 5:00 PM - SEC Filing Form 4 AMARIN CORP PLC\UK For: Apr 18 Filed by: Sterling Louis III April 21, 2026 5:00 PM - SEC Filing Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 April 15, 2026 8:01 AM - Globe NewsWire American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular April 8, 2026 8:01 AM - StreetInsider Form 4 AMARIN CORP PLC\UK For: Apr 01 Filed by: Fishman Peter L. April 2, 2026 4:30 PM - SEC Filing Amarin highlights guideline support for icosapent ethyl in heart risk care March 18, 2026 8:32 AM - StreetInsider Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline March 18, 2026 8:30 AM - StreetInsider Full Article List